Suki Subbiah, MD
Assistant Professor of Clinical Medicine
Dr. Subbiah received her B.A. in Philosophy from Emory University in Atlanta, GA where she was inducted into Phi Beta Kappa. She received her medical degree from the University of Florida in 2006. She completed her residency training in Internal Medicine and her fellowship training in Hematology/Oncology at the University of Florida in Gainesville, FL.
In December 2012, Dr. Subbiah joined the Section of Hematology/Oncology at Tulane University School of Medicine as an Assistant Professor of Clinical Medicine. Her clinical and research interests are lymphoma and hematologic malignancies. She also enjoys participating in the education of fellows, residents, and medical students.
Dr. Subbiah is board certified in Internal Medicine, Hematology, and Medical Oncology.
Subbiah S, O'Connell F, Kobraei K, Ramos-Caro FA, Moreb JS. Unusual Multiple Myeloma Cutaneous Manifestation Following Nonmyeloablative Allogeneic Stem Cell Transplantation. Clinical Advances in Hematology & Oncology 2009;7(12):800-802.
Wenger JB, Santos N, Liu Y, Dallas J, Subbiah S, Hochwald S, Huang EH, Dang DT, Allegra CJ, Luesch H, Dang LH. Can we develop effective combination antiangiogenic therapy for patients with hepatocellular carcinoma? Oncology Reviews 2011;5(3):177-184.
Subbiah S. "Expectations in Third-World Medicine." House Calls 2006;18-19.
Subbiah S, Brown RA, Chang MN, Cogle CR, Hiemenz JW, May WS, Moreb J, Norkin M, Wingard JR, Wirk B, Hsu JW. CECA Results in Improved Response Rates and Ability to Proceed to Stem Cell Transplantation in Adult Refractory or Relapsed Acute Myeloid Leukemia. Blood 2011 (ASH Annual Meeting Abstracts);118:4299.
Escobar C, Subbiah S, Norkin M, Leather H, Richards A, Brown RA, May WS, Wingard JR, Hsu JW, Cogle CR. Reinduction Chemotherapy for AML: Comparison Between CECA, High Dose Cytarabine and CLAG-M. Blood 2011 (ASH Annual Meeting Abstracts);118:4301.
1430 Tulane Ave, New Orleans, LA 70112 504-988-5331 firstname.lastname@example.org